This retrospective observational study looked at 44 children with atypical ulcerative colitis (aUC) in Australia who received oral vancomycin (OV) therapy between 2014 – 2023. This study includes 29 children with both PSC and aUC and 15 children with aUC without PSC. Most of the children who received OV saw reduced UC activity and fecal […]